Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has shared an announcement.
Shandong Xinhua Pharmaceutical Company Limited announced that its Aspirin Enteric-coated Tablets have passed the Generics Drugs Consistency Evaluation, receiving approval from the National Medical Products Administration. This approval signifies a positive step for the company, enhancing its product offerings and potentially strengthening its position in the pharmaceutical market.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a pharmaceutical company based in China, primarily involved in the production and distribution of chemical medicines. The company focuses on prescription drugs and has a market presence in the pharmaceutical industry.
YTD Price Performance: -3.10%
Average Trading Volume: 2,170,030
Technical Sentiment Signal: Sell
Current Market Cap: HK$8.56B
Find detailed analytics on 0719 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue